Evidence map›Paper›PMID 23115187›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport.

David J Mitchell, Kiev R Blasier, Erin D Jeffery, Mitchell W Ross, Ashok K Pullikuth, Dong Suo, Juyeon Park, W Russell Smiley, Kevin W-H Lo, Jeffrey Shabanowitz and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. The neuropathy-causingbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Long-distance regressive signaling in neural development and disease.Wiley interdisciplinary reviews. Developmental biology · 2021
    Review
  16. Article
  17. Article
  18. Axonal transport and neurological disease.Nature reviews. Neurology · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

David J MitchellDepartment of Cell Biology, University of Virginia, Charlottesville, VA 22908, USA.
Kiev R Blasier
Erin D Jeffery
Mitchell W Ross
Ashok K Pullikuth
Dong Suo
Juyeon Park
W Russell Smiley
Kevin W-H Lo
Jeffrey Shabanowitz
Christopher D Deppmann
Jonathan C Trinidad
Donald F Hunt
Andrew D Catling
K Kevin Pfister
University of Virginia · USDivision of Chemistry · USLouisiana State University Health Sciences Center New Orleans · USUniversity of California, San Francisco · US

Funding

YEAST THREONINE &SERINE KINASESP41RR001614 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 1985 to 2011
$24.1M
PROTEIN SEQUENCING BY TANDEM MASS SPECTROMETRYR01GM037537 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUNT, DONALD F · 1987 to 2023
$17.8M
The Role of Cytoplasmic Dynein in Axonal TransportR01GM086472 · NIGMS · UNIVERSITY OF VIRGINIA · PI PFISTER, K. KEVIN · 2008 to 2017
$2.7M
COMBINATORIAL SIGNALING THROUGH MEK1R01GM068111 · NIGMS · LSU HEALTH SCIENCES CENTER · PI CATLING, ANDREW D · 2003 to 2009
$1.7M
Mechanisms of Neuronal Competition During DevelopmentR01NS072388 · NINDS · UNIVERSITY OF VIRGINIA · PI DEPPMANN, CHRISTOPHER D · 2011 to 2015
$1.7M
NCRR NIH HHS P41 RR001614NIGMS NIH HHS GM37537NIGMS NIH HHS R01 GM037537NIGMS NIH HHS R01 GM068111NIGMS NIH HHS R01 GM086472NINDS NIH HHS R01 NS072388
6 · The paper itself

Abstract

The retrograde transport of Trk-containing endosomes from the axon to the cell body by cytoplasmic dynein is necessary for axonal and neuronal survival. We investigated the recruitment of dynein to signaling endosomes in rat embryonic neurons and PC12 cells. We identified a novel phosphoserine on the dynein intermediate chains (ICs), and we observed a time-dependent neurotrophin-stimulated increase in intermediate chain phosphorylation on this site in both cell types. Pharmacological studies, overexpression of constitutively active MAP kinase kinase, and an in vitro assay with recombinant proteins demonstrated that the intermediate chains are phosphorylated by the MAP kinase ERK1/2, extracellular signal-regulated kinase, a major downstream effector of Trk. Live cell imaging with fluorescently tagged IC mutants demonstrated that the dephosphomimic mutants had significantly reduced colocalization with Trk and Rab7, but not a mitochondrial marker. The phosphorylated intermediate chains were enriched on immunoaffinity-purified Trk-containing organelles. Inhibition of ERK reduced the amount of phospho-IC and the total amount of dynein that copurified with the signaling endosomes. In addition, inhibition of ERK1/2 reduced the motility of Rab7- and TrkB-containing endosomes and the extent of their colocalization with dynein in axons. NGF-dependent survival of sympathetic neurons was significantly reduced by the overexpression of the dephosphomimic mutant IC-1B-S80A, but not WT IC-1B, further demonstrating the functional significance of phosphorylation on this site. These results demonstrate that neurotrophin binding to Trk initiates the recruitment of cytoplasmic dynein to signaling endosomes through ERK1/2 phosphorylation of intermediate chains for their subsequent retrograde transport in axons.

Indexed as

AnimalsAxonal TransportBlotting, WesternCell MembraneCell SurvivalCytoplasmDyneinsElectrophoresis, Polyacrylamide GelEndosomesEnzyme ActivationMAP Kinase Signaling SystemNerve Growth FactorNerve Growth FactorsNeuronsOrganellesPC12 CellsDyneinsNerve Growth FactorNerve Growth FactorsReceptor, trkARNA, Small Interfering

Identifiers

PMID23115187
PMCPMC3500848
OpenAlexW1973787420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.